After years of chronic cough and misdiagnosed infections, a 2016 stage 4 ALK-positive lung cancer diagnosis led to targeted therapy that has helped since.
Nancy Pronsati
Advertisement
Nancy Pronsati, vice president of the board of ALK Positive, began her journey in 2014 after multiple misdiagnoses of chronic bronchitis and a persistent cough, which were later identified as stage 4 ALK-positive lung cancer.
Articles by Nancy Pronsati
Advertisement
